SG10201404330VA - Ketoreductase Polypeptides For The Stereoselective Production Of (4S)-3[(5S)-5(4-Fluorophenyl)-5-Hydroxypentanoyl]-4-Phenyl-1,3-Oxazolidin-2-One - Google Patents

Ketoreductase Polypeptides For The Stereoselective Production Of (4S)-3[(5S)-5(4-Fluorophenyl)-5-Hydroxypentanoyl]-4-Phenyl-1,3-Oxazolidin-2-One

Info

Publication number
SG10201404330VA
SG10201404330VA SG10201404330VA SG10201404330VA SG10201404330VA SG 10201404330V A SG10201404330V A SG 10201404330VA SG 10201404330V A SG10201404330V A SG 10201404330VA SG 10201404330V A SG10201404330V A SG 10201404330VA SG 10201404330V A SG10201404330V A SG 10201404330VA
Authority
SG
Singapore
Prior art keywords
hydroxypentanoyl
oxazolidin
fluorophenyl
phenyl
ketoreductase polypeptides
Prior art date
Application number
SG10201404330VA
Other languages
English (en)
Inventor
Emily Mundorff
Vries Erik De
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Publication of SG10201404330VA publication Critical patent/SG10201404330VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/002Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01184Carbonyl reductase (NADPH) (1.1.1.184)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SG10201404330VA 2008-08-29 2009-08-20 Ketoreductase Polypeptides For The Stereoselective Production Of (4S)-3[(5S)-5(4-Fluorophenyl)-5-Hydroxypentanoyl]-4-Phenyl-1,3-Oxazolidin-2-One SG10201404330VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9280708P 2008-08-29 2008-08-29

Publications (1)

Publication Number Publication Date
SG10201404330VA true SG10201404330VA (en) 2014-10-30

Family

ID=41722237

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201404330VA SG10201404330VA (en) 2008-08-29 2009-08-20 Ketoreductase Polypeptides For The Stereoselective Production Of (4S)-3[(5S)-5(4-Fluorophenyl)-5-Hydroxypentanoyl]-4-Phenyl-1,3-Oxazolidin-2-One

Country Status (6)

Country Link
US (11) US8273554B2 (de)
EP (1) EP2329014B1 (de)
CN (1) CN102186972B (de)
SG (1) SG10201404330VA (de)
SI (1) SI2329014T1 (de)
WO (1) WO2010025085A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674248A (en) * 1995-01-23 1997-10-07 Angeion Corporation Staged energy concentration for an implantable biomedical device
US7977078B2 (en) 2007-08-24 2011-07-12 Codexis, Inc. Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane
JP5973131B2 (ja) 2007-09-13 2016-08-23 コデクシス, インコーポレイテッド アセトフェノンの還元のためのケトレダクターゼポリペプチド
SI2205727T1 (sl) 2007-10-01 2015-09-30 Codexis, Inc. Polipeptidi ketoreduktaze za izdelavo azetidinona
WO2010025085A2 (en) 2008-08-29 2010-03-04 Codexis, Inc. Ketoreductase polypeptides for the stereoselective production of (4s)-3[(5s)-5(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one
WO2010113175A2 (en) 2009-04-01 2010-10-07 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
SG10201405022PA (en) 2009-08-19 2014-10-30 Codexis Inc Ketoreductase polypeptides for the preparation of phenylephrine
US9040262B2 (en) 2010-05-04 2015-05-26 Codexis, Inc. Biocatalysts for ezetimibe synthesis
DK2649187T3 (da) 2010-12-08 2018-01-29 Codexis Inc Biokatalysatorer og fremgangsmåder til syntesen af armodafinil
EP2697662B1 (de) * 2011-04-13 2018-06-06 Codexis, Inc. Biokatalytisches verfahren zur herstellung von eslicarbazepin und analoga davon
EP2771006B1 (de) 2011-10-27 2016-05-25 Merck Sharp & Dohme Corp. Verfahren zur herstellung von beta-3-agonisten und zwischenprodukten
EP2770996B1 (de) 2011-10-27 2016-09-28 Merck Sharp & Dohme Corp. Verfahren zur herstellung von beta-3-agonisten und zwischenprodukten davon
IN2014CN04470A (de) 2011-11-18 2015-09-04 Codexis Inc
HUE042605T2 (hu) * 2012-05-08 2019-07-29 Codexis Inc Biokatalizátorok és kémiai vegyületek hidroxilálására szolgáló eljárások
CN104428313B (zh) 2012-05-11 2017-11-17 科德克希思公司 工程化亚胺还原酶以及用于酮和胺化合物的还原胺化的方法
CN102827851B (zh) * 2012-09-06 2013-11-13 江苏阿尔法药业有限公司 一种酮还原酶基因及其应用
EP2970927A4 (de) 2013-03-15 2016-10-12 Merck Sharp & Dohme Immobilisierte ketoreduktasen und verfahren zur herstellung und verwendung immobilisierter ketoreduktasen
EP2968269B1 (de) 2013-03-15 2019-07-10 Merck Sharp & Dohme Corp. Verfahren zur herstellung von beta-3-agonisten und zwischenprodukten davon
CN104342411B (zh) * 2013-07-26 2017-09-29 南京朗恩生物科技有限公司 活性增强的酮还原酶突变体、编码序列及其制备方法
CN104342412B (zh) * 2013-08-09 2018-12-21 南京朗恩生物科技有限公司 用于生产(s)-4-氯-3-羟基丁酸乙酯的酮还原酶突变体
WO2015039675A1 (en) 2013-09-23 2015-03-26 Pharmathen S.A. Novel process for the preparation of ezetimibe intermediates
JP6643987B2 (ja) 2013-11-13 2020-02-12 コデクシス, インコーポレイテッド ケトン化合物およびアミン化合物の還元的アミノ化のための操作されたイミンレダクターゼおよび方法
CN112898210A (zh) 2013-11-15 2021-06-04 豪夫迈·罗氏有限公司 用于制备嘧啶基环戊烷化合物的方法
WO2015162064A1 (en) 2014-04-22 2015-10-29 C-Lecta Gmbh Ketoreductases
EP3224354B1 (de) 2014-11-25 2021-01-13 Codexis, Inc. Manipulierte iminreduktasen und verfahren zur reduktiven aminierung von keton- und aminverbindungen
WO2017001907A1 (en) 2015-06-29 2017-01-05 Teva Pharmaceuticals International Gmbh Biocatalytic processes for the preparation of vilanterol
CN107435042A (zh) * 2016-05-26 2017-12-05 尚科生物医药(上海)有限公司 重组酮还原酶在制备(r)‑3‑奎宁醇中的应用
CN106011095B (zh) * 2016-07-27 2021-02-26 苏州汉酶生物技术有限公司 工程化酮还原酶多肽及使用其制备依替米贝中间体的方法
CN110914446B (zh) 2017-07-14 2024-02-06 C-乐克塔股份有限公司 酮还原酶
CN109576312B (zh) * 2017-09-29 2021-08-24 尚科生物医药(上海)有限公司 一种制备(r)- 2-氯-1-(3-羟基苯基)乙醇的方法
CN109055324B (zh) * 2018-07-10 2021-05-04 天津迪沙医药技术开发有限公司 一种改进的酮还原酶及其应用
CN109097412A (zh) * 2018-07-24 2018-12-28 江苏理工学院 一种生物法合成依折麦布中间体的方法
CN109943543B (zh) * 2019-03-28 2020-12-11 上海健康医学院 醇脱氢酶突变体及其制备方法和应用
WO2024013383A1 (en) * 2022-07-15 2024-01-18 F. Hoffmann-La Roche Ag Mutant ketoreductase with increased ketoreductase activity as well as methods and uses involving the same

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2045180T3 (es) 1987-05-04 1994-01-16 Ciba Geigy Ag Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
US5538867A (en) 1988-09-13 1996-07-23 Elf Aquitaine Process for the electrochemical regeneration of pyridine cofactors
JPH0623150B2 (ja) 1988-11-15 1994-03-30 高砂香料工業株式会社 光学活性3−ヒドロキシブタン酸類の製造方法
DE4014573C1 (de) 1990-05-07 1991-10-10 Forschungszentrum Juelich Gmbh, 5170 Juelich, De
US5225339A (en) 1992-02-26 1993-07-06 The Scripps Research Institute Lactobacillus kefir alcohol dehydrogenase
US5385833A (en) 1992-02-26 1995-01-31 The Scripps Research Institute Pseudomonas sp. ATCC No. 49794 alcohol dehydrogenase
CA2103932A1 (en) * 1992-11-05 1994-05-06 Ramesh N. Patel Stereoselective reduction of ketones
JP3155107B2 (ja) 1993-01-12 2001-04-09 ダイセル化学工業株式会社 光学活性4−ハロ−3−ヒドロキシ酪酸エステルの製造方法
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5491077A (en) 1994-07-20 1996-02-13 Merck & Co., Inc. Microbial method
US5427933A (en) 1994-07-20 1995-06-27 Merck & Co., Inc. Reduction of phenylalkyl ketones to the corresponding (S)-hydroxy derivatives using mucor hiemalis IFO 5834
CN1159444C (zh) 1994-08-12 2004-07-28 Dsm公司 突变的青霉素g酰基转移酶基因
JPH08336393A (ja) 1995-04-13 1996-12-24 Mitsubishi Chem Corp 光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法
JP2948504B2 (ja) 1995-05-11 1999-09-13 高砂香料工業株式会社 光学活性アゼチジン−2−オン誘導体の製造方法
US5618707A (en) 1996-01-04 1997-04-08 Schering Corporation Stereoselective microbial reduction of 5-fluorophenyl-5-oxo-pentanoic acid and a phenyloxazolidinone condensation product thereof
DE19610984A1 (de) 1996-03-21 1997-09-25 Boehringer Mannheim Gmbh Alkohol-Dehydrogenase und deren Verwendung zur enzymatischen Herstellung chiraler Hydroxyverbindungen
US5891685A (en) 1996-06-03 1999-04-06 Mitsubishi Chemical Corporation Method for producing ester of (S)-γ-halogenated-β-hydroxybutyric acid
DE19812004A1 (de) 1998-03-19 1999-09-30 Forschungszentrum Juelich Gmbh Dehydrogenasen mit verbesserter NAD-Abhängigkeit, deren Herstellung und Verwendung
US6495023B1 (en) 1998-07-09 2002-12-17 Michigan State University Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration
US6207822B1 (en) 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
DE19857302C2 (de) 1998-12-14 2000-10-26 Forschungszentrum Juelich Gmbh Verfahren zur enantioselektiven Reduktion von 3,5-Dioxocarbonsäuren, deren Salze und Ester
JP2000236883A (ja) 1998-12-21 2000-09-05 Daicel Chem Ind Ltd 新規なカルボニル還元酵素、該酵素の製造方法、該酵素をコードするdnaおよびこれを利用したアルコールの製造方法
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
CA2360376C (en) 1999-12-03 2005-04-26 Noriyuki Kizaki Novel carbonyl reductase, gene thereof and method of using the same
TWI275645B (en) 2000-02-16 2007-03-11 Daicel Chemical Industries Ltd. (R)-2-octanol dehydrogenases, methods for producing the enzymes, DNA encoding the enzymes, and methods for producing alcohols using the enzymes
EP1272967A2 (de) 2000-03-30 2003-01-08 Maxygen, Inc. In silico übekreuzungsortsauswahl
DE10037101A1 (de) 2000-07-27 2002-02-07 Degussa Rekombinant hergestellte Enzyme mit verbesserter NAD(H)-Akzeptanz
US7202070B2 (en) 2000-10-31 2007-04-10 Biocatalytics, Inc. Method for reductive amination of a ketone using a mutated enzyme
PL364577A1 (en) 2001-03-22 2004-12-13 Bristol-Myers Squibb Company Stereoselective reduction of substituted acetophenone
DE60206365T2 (de) 2001-03-28 2006-07-06 Schering Corporation, Kenilworth Verfahren für die enantioselektive synthese von azetidinon-zwischenprodukten
DE10119274A1 (de) 2001-04-20 2002-10-31 Juelich Enzyme Products Gmbh Enzymatisches Verfahren zur enantioselektiven Reduktion von Ketoverbindungen
MXPA04006304A (es) 2001-12-27 2004-10-04 Dsm Ip Assets Bv Proceso de preparacion de antibioticos de ?-lactama.
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
JP4213524B2 (ja) 2003-04-17 2009-01-21 ダイセル化学工業株式会社 新規なカルボニル還元酵素、その酵素をコードするdnaを含むポリヌクレオチド、その製造方法、およびこれを利用した光学活性アルコールの製造方法
DE10327454A1 (de) 2003-06-18 2005-01-20 Juelich Enzyme Products Gmbh Oxidoreduktase aus Pichia capsulata
WO2005017135A1 (en) 2003-08-11 2005-02-24 Codexis, Inc. Improved ketoreductase polypeptides and related polynucleotides
EP1660648B1 (de) 2003-08-11 2013-10-09 Codexis, Inc. Verbesserte glucosedehydrogenase-polypeptide und zugehörige polynukleotide
JP2007502111A (ja) 2003-08-11 2007-02-08 コデクシス, インコーポレイテッド 4−置換3−ヒドロキシ酪酸誘導体およびビシナルなシアノ,ヒドロキシ置換カルボン酸エステルの生成のための酵素的プロセス
DE10345772A1 (de) 2003-10-01 2005-04-21 Basf Ag Verfahren zur Herstellung von 3-Methylamino-1-(thien-2-yl)-propan-1-ol
US7067675B2 (en) 2003-11-24 2006-06-27 Hetero Drugs Limited Process for ezetimibe intermediate
JP4394647B2 (ja) 2003-12-02 2010-01-06 メルシャン株式会社 光学活性テトラヒドロチオフェン誘導体の製造方法、および、光学活性テトラヒドロチオフェン−3−オールの晶析方法
US7393667B2 (en) 2005-05-31 2008-07-01 Bristol-Myers Squibb Company Stereoselective reduction process for the preparation of pyrrolotriazine compounds
WO2007010944A1 (ja) 2005-07-20 2007-01-25 Kaneka Corporation 光学活性2-(n-置換アミノメチル)-3-ヒドロキシ酪酸エステル類の製造方法
AT502395B1 (de) 2005-07-27 2007-03-15 Iep Gmbh Oxidoreduktasen zur stereoselektiven reduktion von ketoverbindungen
EP2066788B1 (de) 2006-10-02 2014-07-23 Codexis, Inc. Zusammensetzungen und verfahren zur herstellung stereoisomerenreiner statine und synthetische zwischenprodukte dafür
CN101627116B (zh) 2007-02-08 2013-07-10 科德克希思公司 酮还原酶及其用途
US7977078B2 (en) 2007-08-24 2011-07-12 Codexis, Inc. Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane
JP5973131B2 (ja) 2007-09-13 2016-08-23 コデクシス, インコーポレイテッド アセトフェノンの還元のためのケトレダクターゼポリペプチド
WO2009042984A1 (en) 2007-09-28 2009-04-02 Codexis, Inc. Ketoreductase polypeptides and uses thereof
SI2205727T1 (sl) 2007-10-01 2015-09-30 Codexis, Inc. Polipeptidi ketoreduktaze za izdelavo azetidinona
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
WO2010025085A2 (en) 2008-08-29 2010-03-04 Codexis, Inc. Ketoreductase polypeptides for the stereoselective production of (4s)-3[(5s)-5(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one
SG10201405022PA (en) * 2009-08-19 2014-10-30 Codexis Inc Ketoreductase polypeptides for the preparation of phenylephrine

Also Published As

Publication number Publication date
US10246687B2 (en) 2019-04-02
US9422530B2 (en) 2016-08-23
US20100062499A1 (en) 2010-03-11
EP2329014B1 (de) 2014-10-22
CN102186972A (zh) 2011-09-14
US9796964B2 (en) 2017-10-24
US20190161740A1 (en) 2019-05-30
US20130210098A1 (en) 2013-08-15
US8956840B2 (en) 2015-02-17
US8273554B2 (en) 2012-09-25
US10988739B2 (en) 2021-04-27
US8415126B2 (en) 2013-04-09
US20160376565A1 (en) 2016-12-29
US20150132806A1 (en) 2015-05-14
US20200095561A1 (en) 2020-03-26
US10047348B2 (en) 2018-08-14
US20180023059A1 (en) 2018-01-25
US20150337272A1 (en) 2015-11-26
US20210222135A1 (en) 2021-07-22
EP2329014A4 (de) 2012-03-21
SI2329014T1 (sl) 2015-01-30
WO2010025085A3 (en) 2010-04-15
EP2329014A2 (de) 2011-06-08
US10544401B2 (en) 2020-01-28
CN102186972B (zh) 2014-08-20
WO2010025085A2 (en) 2010-03-04
US20120322136A1 (en) 2012-12-20
US9139820B2 (en) 2015-09-22
US20180312817A1 (en) 2018-11-01

Similar Documents

Publication Publication Date Title
SG10201404330VA (en) Ketoreductase Polypeptides For The Stereoselective Production Of (4S)-3[(5S)-5(4-Fluorophenyl)-5-Hydroxypentanoyl]-4-Phenyl-1,3-Oxazolidin-2-One
HUS1700031I1 (hu) JAK inhibitor azetidin és ciklobután származékok
BR112012003704A2 (pt) derivados de 3-amino-5-fenil-5,6-di-hidro-2h[1,4]oxazina
IL232707A0 (en) Catorductase-type polypeptides for the production of azetidinone
EP2438053A4 (de) Verfahren zur synthetisierung von 3-(substituiertem dihydroisoindolinon-2-yl)-2,6-dioxopiperidin und zwischenprodukten davon
WO2010122578A3 (en) Process for preparation of sitagliptin and its intermediates
EP2518126A4 (de) Zusammensetzung für ein wärmespeichermaterial und wärmespeichermaterial
EP2509423A4 (de) Verfahren zur herstellung von deferasirox und deferasirox-polymorphe
EP2269994A4 (de) Die polymorphe von 4-anilinochinazolinderivaten, deren herstellung und deren verwendungen
AU2009252756A8 (en) Nanometric-sized ceramic materials, process for their synthesis and uses thereof
GB0721467D0 (en) Biomethane purifying process & cell wall disruption process
IL213607A0 (en) 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
DE602007014191D1 (en) Malatsalze und polymorphe von (3s,5s)-7-ä3-amino-5-methyl-piperidinylü-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure
PL2044099T3 (pl) Sposób wytwarzania S-fluorometylo-6,9-difluoro-11-hydroksy-16-metylo-17-propionyloksy-3-okso-androsta-1,4-dieno-17-karbotionianu oraz związki pośrednie
EP2383260A3 (de) Verfahren zur Herstellung von Statine
IL211062A0 (en) Pharmaceutical uses of lanosta-8,24-dien-3-ols
EP2272902B8 (de) Poröse folie, herstellungsverfahren dafür und wärmedämmfolie
EP2208729A4 (de) Oxazolidinonderivat mit 7-gliedrigem heteroring
WO2009111785A3 (en) Treatment of sepsis with 5-ethyl-1-phenyl-2(1h)-pyridone and novel methods for synthesis
WO2008021385A3 (en) Processes for preparing intermediates of pemetrexed
WO2010036904A3 (en) Preparation of valganciclovir and its salts
AU2008902718A0 (en) Cutting of thin-walled vessels
PL381904A1 (pl) Sposób prowadzenia fermentacji etanolowej nastawów wysokocukrowych
PL386732A1 (pl) Nowe azobenzenowe pochodne fenolu, zawierające pierścień heterocykliczny
AU2007100865A4 (en) Dynamic Location Aware Search